866-997-4948(US-Canada Toll Free)

Parkinsons Disease - Pipeline Review, H1 2014

Published By :

Global Markets Direct

Published Date : Feb 2014

Category :

Diseases & Conditions

No. of Pages : 775 Pages

Global Markets Direct’s, ‘Parkinson\'s Disease - Pipeline Review, H1 2014’, provides an overview of the Parkinson\'s Disease’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Parkinson\'s Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Parkinson\'s Disease and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Parkinson\'s Disease
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Parkinson\'s Disease and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Parkinson\'s Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Parkinson\'s Disease pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Parkinson\'s Disease
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Parkinson\'s Disease pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Content

Introduction
Parkinson\'s Disease Overview
Therapeutics Development
Parkinson\'s Disease - Therapeutics under Development by Companies
Parkinson\'s Disease - Therapeutics under Investigation by Universities/Institutes
Parkinson\'s Disease - Pipeline Products Glance
Parkinson\'s Disease - Products under Development by Companies
Parkinson\'s Disease - Products under Investigation by Universities/Institutes
Parkinson\'s Disease - Companies Involved in Therapeutics Development
Parkinson\'s Disease - Therapeutics Assessment
Drug Profiles
Parkinson\'s Disease - Recent Pipeline Updates
Parkinson\'s Disease - Dormant Projects
Parkinson\'s Disease - Discontinued Products
Parkinson\'s Disease - Product Development Milestones

Appendix

List of Table


Number of Products under Development for Parkinson\'s Disease, H1 2014
Number of Products under Development for Parkinson\'s Disease - Comparative Analysis, H1 2014
Number of Products under Development by Companies, H1 2014
Number of Products under Development by Companies, H1 2014 (Contd..1)
Number of Products under Development by Companies, H1 2014 (Contd..2)
Number of Products under Development by Companies, H1 2014 (Contd..3)
Number of Products under Development by Companies, H1 2014 (Contd..4)
Number of Products under Development by Companies, H1 2014 (Contd..5)
Number of Products under Development by Companies, H1 2014 (Contd..6)
Number of Products under Development by Companies, H1 2014 (Contd..7)
Number of Products under Development by Companies, H1 2014 (Contd..8)
Number of Products under Development by Companies, H1 2014 (Contd..9)
Number of Products under Development by Companies, H1 2014 (Contd..10)
Number of Products under Development by Companies, H1 2014 (Contd..11)
Number of Products under Development by Companies, H1 2014 (Contd..12)
Number of Products under Investigation by Universities/Institutes, H1 2014
Number of Products under Investigation by Universities/Institutes, H1 2014 (Contd..1)
Number of Products under Investigation by Universities/Institutes, H1 2014 (Contd..2)
Comparative Analysis by Late Stage Development, H1 2014
Comparative Analysis by Clinical Stage Development, H1 2014
Comparative Analysis by Early Stage Development, H1 2014
Comparative Analysis by Unknown Stage Development, H1 2014
Products under Development by Companies, H1 2014
Products under Development by Companies, H1 2014 (Contd..1)
Products under Development by Companies, H1 2014 (Contd..2)
Products under Development by Companies, H1 2014 (Contd..3)
Products under Development by Companies, H1 2014 (Contd..4)
Products under Development by Companies, H1 2014 (Contd..5)
Products under Development by Companies, H1 2014 (Contd..6)
Products under Development by Companies, H1 2014 (Contd..7)
Products under Development by Companies, H1 2014 (Contd..8)
Products under Development by Companies, H1 2014 (Contd..9)
Products under Development by Companies, H1 2014 (Contd..10)
Products under Development by Companies, H1 2014 (Contd..11)
Products under Development by Companies, H1 2014 (Contd..12)
Products under Development by Companies, H1 2014 (Contd..13)
Products under Development by Companies, H1 2014 (Contd..14)
Products under Development by Companies, H1 2014 (Contd..15)
Products under Investigation by Universities/Institutes, H1 2014
Products under Investigation by Universities/Institutes, H1 2014 (Contd..1)
Products under Investigation by Universities/Institutes, H1 2014 (Contd..2)
Parkinson\'s Disease - Pipeline by Bristol-Myers Squibb Company, H1 2014
Parkinson\'s Disease - Pipeline by Genzyme Corporation, H1 2014
Parkinson\'s Disease - Pipeline by Boehringer Ingelheim GmbH, H1 2014
Parkinson\'s Disease - Pipeline by Kyowa Hakko Kirin Co., Ltd., H1 2014
Parkinson\'s Disease - Pipeline by Biogen Idec Inc., H1 2014
Parkinson\'s Disease - Pipeline by Allergan, Inc., H1 2014
Parkinson\'s Disease - Pipeline by OXIS International, Inc., H1 2014
Parkinson\'s Disease - Pipeline by NsGene A/S, H1 2014
Parkinson\'s Disease - Pipeline by Sanofi, H1 2014
Parkinson\'s Disease - Pipeline by AstraZeneca PLC, H1 2014
Parkinson\'s Disease - Pipeline by GlaxoSmithKline plc, H1 2014
Parkinson\'s Disease - Pipeline by Genentech, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Merck & Co., Inc., H1 2014
Parkinson\'s Disease - Pipeline by Dainippon Sumitomo Pharma Co., Ltd., H1 2014
Parkinson\'s Disease - Pipeline by Euroscreen S.A., H1 2014
Parkinson\'s Disease - Pipeline by Oxford BioMedica plc, H1 2014
Parkinson\'s Disease - Pipeline by Sangamo BioSciences, Inc., H1 2014
Parkinson\'s Disease - Pipeline by NeuroDerm Ltd., H1 2014
Parkinson\'s Disease - Pipeline by Takeda Pharmaceutical Company Limited, H1 2014
Parkinson\'s Disease - Pipeline by Vectura Group plc, H1 2014
Parkinson\'s Disease - Pipeline by XenoPort, Inc., H1 2014
Parkinson\'s Disease - Pipeline by ViaCord, LLC, H1 2014
Parkinson\'s Disease - Pipeline by BioLineRx, Ltd., H1 2014
Parkinson\'s Disease - Pipeline by ApoPharma Inc., H1 2014
Parkinson\'s Disease - Pipeline by Reliance Life Sciences Pvt. Ltd., H1 2014
Parkinson\'s Disease - Pipeline by Aposense Ltd., H1 2014
Parkinson\'s Disease - Pipeline by Novartis AG, H1 2014
Parkinson\'s Disease - Pipeline by EnVivo Pharmaceuticals, H1 2014
Parkinson\'s Disease - Pipeline by Depomed, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Elan Corporation, plc, H1 2014
Parkinson\'s Disease - Pipeline by H. Lundbeck A/S, H1 2014
Parkinson\'s Disease - Pipeline by Jeil Pharmaceutical Co., Ltd., H1 2014
Parkinson\'s Disease - Pipeline by Ono Pharmaceutical Co., Ltd., H1 2014
Parkinson\'s Disease - Pipeline by Orion Oyj, H1 2014
Parkinson\'s Disease - Pipeline by Pfizer Inc., H1 2014
Parkinson\'s Disease - Pipeline by Sigma-Tau S.p.A., H1 2014
Parkinson\'s Disease - Pipeline by Teva Pharmaceutical Industries Limited, H1 2014
Parkinson\'s Disease - Pipeline by UCB S.A., H1 2014
Parkinson\'s Disease - Pipeline by Hadasit Medical Research Services & Development Ltd, H1 2014
Parkinson\'s Disease - Pipeline by Impax Laboratories, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Vernalis plc., H1 2014
Parkinson\'s Disease - Pipeline by OPKO Health, Inc., H1 2014
Parkinson\'s Disease - Pipeline by NuPathe Inc., H1 2014
Parkinson\'s Disease - Pipeline by Aeolus Pharmaceuticals, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Addex Therapeutics, H1 2014
Parkinson\'s Disease - Pipeline by Harbor Therapeutics, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Imugene Limited, H1 2014
Parkinson\'s Disease - Pipeline by Neuralstem, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Amicus Therapeutics, Inc., H1 2014
Parkinson\'s Disease - Pipeline by International Stem Cell Corporation, H1 2014
Parkinson\'s Disease - Pipeline by Mesoblast Limited, H1 2014
Parkinson\'s Disease - Pipeline by Bionomics Limited, H1 2014
Parkinson\'s Disease - Pipeline by Neuren Pharmaceuticals Limited, H1 2014
Parkinson\'s Disease - Pipeline by NeuroSearch A/S, H1 2014
Parkinson\'s Disease - Pipeline by Cortex Pharmaceuticals, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Acadia Pharmaceuticals Inc., H1 2014
Parkinson\'s Disease - Pipeline by Alnylam Pharmaceuticals, Inc., H1 2014
Parkinson\'s Disease - Pipeline by ProteoTech, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Hisamitsu Pharmaceutical Co., Inc., H1 2014
Parkinson\'s Disease - Pipeline by Repligen Corporation, H1 2014
Parkinson\'s Disease - Pipeline by Prana Biotechnology Limited, H1 2014
Parkinson\'s Disease - Pipeline by AnGes MG, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Suven Life Sciences Ltd., H1 2014
Parkinson\'s Disease - Pipeline by CrystalGenomics, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Newron Pharmaceuticals S.p.A., H1 2014
Parkinson\'s Disease - Pipeline by Huons Co., Ltd., H1 2014
Parkinson\'s Disease - Pipeline by Raptor Pharmaceuticals Corp., H1 2014
Parkinson\'s Disease - Pipeline by e-Therapeutics plc, H1 2014
Parkinson\'s Disease - Pipeline by tesa Labtec GmbH, H1 2014
Parkinson\'s Disease - Pipeline by Oryzon Genomics S.A., H1 2014
Parkinson\'s Disease - Pipeline by M et P Pharma AG, H1 2014
Parkinson\'s Disease - Pipeline by TauRx Therapeutics Ltd, H1 2014
Parkinson\'s Disease - Pipeline by AFFiRiS AG, H1 2014
Parkinson\'s Disease - Pipeline by Accera, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Advinus Therapeutics Ltd., H1 2014
Parkinson\'s Disease - Pipeline by Scynexis, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Chipscreen Biosciences Ltd, H1 2014
Parkinson\'s Disease - Pipeline by Upsher-Smith Laboratories, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Osmotica Pharmaceutical Corp., H1 2014
Parkinson\'s Disease - Pipeline by Snowdon Inc., H1 2014
Parkinson\'s Disease - Pipeline by Domain Therapeutics SA, H1 2014
Parkinson\'s Disease - Pipeline by reMYND, H1 2014
Parkinson\'s Disease - Pipeline by Abiogen Pharma S.p.A., H1 2014
Parkinson\'s Disease - Pipeline by Motac Neuroscience Ltd, H1 2014
Parkinson\'s Disease - Pipeline by Neuroprofile GmbH, H1 2014
Parkinson\'s Disease - Pipeline by Wellstat Therapeutics Corporation, H1 2014
Parkinson\'s Disease - Pipeline by Oncodesign SA, H1 2014
Parkinson\'s Disease - Pipeline by Trophos SA, H1 2014
Parkinson\'s Disease - Pipeline by Curemark, LLC, H1 2014
Parkinson\'s Disease - Pipeline by Intec Pharma ltd., H1 2014
Parkinson\'s Disease - Pipeline by InterMed Discovery GmbH, H1 2014
Parkinson\'s Disease - Pipeline by Medeia Therapeutics Ltd., H1 2014
Parkinson\'s Disease - Pipeline by MedGenesis Therapeutix Inc., H1 2014
Parkinson\'s Disease - Pipeline by AngioChem Inc., H1 2014
Parkinson\'s Disease - Pipeline by Metabolic Solutions Development Co., H1 2014
Parkinson\'s Disease - Pipeline by Trevena, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Fabre-Kramer Pharmaceuticals, Inc., H1 2014
Parkinson\'s Disease - Pipeline by BioArctic Neuroscience AB, H1 2014
Parkinson\'s Disease - Pipeline by Indus Biotech Private Limited, H1 2014
Parkinson\'s Disease - Pipeline by Affichem, H1 2014
Parkinson\'s Disease - Pipeline by QR Pharma, Inc., H1 2014
Parkinson\'s Disease - Pipeline by NeuroNascent, Inc., H1 2014
Parkinson\'s Disease - Pipeline by KineMed, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Dart NeuroScience LLC, H1 2014
Parkinson\'s Disease - Pipeline by QRxPharma Limited, H1 2014
Parkinson\'s Disease - Pipeline by Omeros Corporation, H1 2014
Parkinson\'s Disease - Pipeline by Intra-Cellular Therapies, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Targacept, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Obio Pharmaceutical Holdings Limited, H1 2014
Parkinson\'s Disease - Pipeline by Cellceutix Corporation, H1 2014
Parkinson\'s Disease - Pipeline by SanBio, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Tautatis Incorporated, H1 2014
Parkinson\'s Disease - Pipeline by Proteostasis Therapeutics, Inc., H1 2014
Parkinson\'s Disease - Pipeline by M\'s Science Corporation, H1 2014
Parkinson\'s Disease - Pipeline by Stelic Institute & Co., H1 2014
Parkinson\'s Disease - Pipeline by Cynapsus Therapeutics, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Bial - Portela & Ca, S.A., H1 2014
Parkinson\'s Disease - Pipeline by Pharnext SAS, H1 2014
Parkinson\'s Disease - Pipeline by Heptares Therapeutics Ltd., H1 2014
Parkinson\'s Disease - Pipeline by Ascendis Pharma A/S, H1 2014
Parkinson\'s Disease - Pipeline by Signum Biosciences, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Neuraltus Pharmaceuticals, Inc., H1 2014
Parkinson\'s Disease - Pipeline by RhinoCyte, Inc., H1 2014
Parkinson\'s Disease - Pipeline by ArmaGen Technologies, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Edison Pharmaceuticals, Inc., H1 2014
Parkinson\'s Disease - Pipeline by CHA Bio & Diostech Co., Ltd., H1 2014
Parkinson\'s Disease - Pipeline by Gene Solutions LLC, H1 2014
Parkinson\'s Disease - Pipeline by Clera Inc., H1 2014
Parkinson\'s Disease - Pipeline by Genosco, H1 2014
Parkinson\'s Disease - Pipeline by Varinel, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Luye Pharma Group Ltd., H1 2014
Parkinson\'s Disease - Pipeline by Promentis Pharmaceuticals, Inc., H1 2014
Parkinson\'s Disease - Pipeline by iPierian, Inc, H1 2014
Parkinson\'s Disease - Pipeline by SignPath Pharma Inc, H1 2014
Parkinson\'s Disease - Pipeline by STATegics, Inc., H1 2014
Parkinson\'s Disease - Pipeline by PharmaNeuroBoost NV, H1 2014
Parkinson\'s Disease - Pipeline by Neuron Biopharma SA, H1 2014
Parkinson\'s Disease - Pipeline by Selvita S.A, H1 2014
Parkinson\'s Disease - Pipeline by Amarantus Bioscience Holdings, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Cell Cure Neurosciences, Ltd., H1 2014
Parkinson\'s Disease - Pipeline by VivaCell Biotechnology Espana S.L., H1 2014
Parkinson\'s Disease - Pipeline by Genervon Biopharmaceuticals, LLC, H1 2014
Parkinson\'s Disease - Pipeline by Civitas Therapeutics, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Lead Discovery Center GmbH, H1 2014
Parkinson\'s Disease - Pipeline by NeuroPhage Pharmaceuticals, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Hermo Pharma Oy, H1 2014
Parkinson\'s Disease - Pipeline by Bionure, H1 2014
Parkinson\'s Disease - Pipeline by Pharma Two B Ltd., H1 2014
Parkinson\'s Disease - Pipeline by Serina Therapeutics, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Valens Therapeutics, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Arrien Pharmaceuticals, LLC, H1 2014
Parkinson\'s Disease - Pipeline by CalAsia Pharmaceuticals, Inc., H1 2014
Parkinson\'s Disease - Pipeline by SK Biopharmaceuticals Co., Ltd., H1 2014
Parkinson\'s Disease - Pipeline by Io Therapeutics, Inc., H1 2014
Parkinson\'s Disease - Pipeline by Chronos Therapeutics Limited, H1 2014
Parkinson\'s Disease - Pipeline by UniQure BV, H1 2014
Parkinson\'s Disease - Pipeline by nLife Therapeutics, S.L., H1 2014
Parkinson\'s Disease - Pipeline by Neurodyn Inc., H1 2014
Parkinson\'s Disease - Pipeline by AbbVie Inc., H1 2014
Parkinson\'s Disease - Pipeline by Prexton Therapeutics SA, H1 2014
Parkinson\'s Disease - Pipeline by Angita B.V., H1 2014
Parkinson\'s Disease - Pipeline by Inventiva SAS, H1 2014
Parkinson\'s Disease - Pipeline by Netherlands Translational Research Center B.V., H1 2014
Parkinson\'s Disease - Pipeline by Neurolixis Inc., H1 2014
Parkinson\'s Disease - Pipeline by Bionature E.A. Ltd., H1 2014
Assessment by Monotherapy Products, H1 2014
Assessment by Combination Products, H1 2014
Number of Products by Stage and Target, H1 2014
Number of Products by Stage and Mechanism of Action, H1 2014
Number of Products by Stage and Route of Administration, H1 2014
Number of Products by Stage and Molecule Type, H1 2014
Parkinson\'s Disease Therapeutics - Recent Pipeline Updates, H1 2014
Parkinson\'s Disease - Dormant Projects, H1 2014
Parkinson\'s Disease - Dormant Projects (Contd..1), H1 2014
Parkinson\'s Disease - Dormant Projects (Contd..2), H1 2014
Parkinson\'s Disease - Dormant Projects (Contd..3), H1 2014
Parkinson\'s Disease - Dormant Projects (Contd..4), H1 2014
Parkinson\'s Disease - Dormant Projects (Contd..5), H1 2014
Parkinson\'s Disease - Dormant Projects (Contd..6), H1 2014
Parkinson\'s Disease - Dormant Projects (Contd..7), H1 2014
Parkinson\'s Disease - Dormant Projects (Contd..8), H1 2014
Parkinson\'s Disease - Dormant Projects (Contd..9), H1 2014
Parkinson\'s Disease - Discontinued Products, H1 2014

List of Chart


Number of Products under Development for Parkinson\'s Disease, H1 2014
Number of Products under Development for Parkinson\'s Disease - Comparative Analysis, H1 2014
Number of Products under Development by Companies, H1 2014
Number of Products under Investigation by Universities/Institutes, H1 2014
Comparative Analysis by Late Stage Development, H1 2014
Comparative Analysis by Clinical Stage Development, H1 2014
Comparative Analysis by Early Stage Products, H1 2014
Comparative Analysis by Unknown Stage Development, H1 2014
Assessment by Monotherapy Products, H1 2014
Assessment by Combination Products, H1 2014
Number of Products by Top 10 Target, H1 2014
Number of Products by Stage and Top 10 Target, H1 2014
Number of Products by Top 10 Mechanism of Action, H1 2014
Number of Products by Stage and Top 10 Mechanism of Action, H1 2014
Number of Products by Top 10 Route of Administration, H1 2014
Number of Products by Stage and Top 10 Route of Administration, H1 2014
Number of Products by Top 10 Molecule Type, H1 2014
Number of Products by Stage and Top 10 Molecule Type, H1 2014

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *